Botox
The first and only treatment FDA approved to temporarily improve the look of moderate to severe frown lines, crow’s feet, forehead lines, and vertical bands connecting the neck and jaw in adults.
Treatment requires minimal downtime. You can return to your daily routine immediately after you leave your specialist’s office.
You may begin to notice results within 24 to 48 hours for moderate to severe frown lines.
It delivers predictable, subtle results, so you look like you, only with less noticeable facial lines.
SAVE ON YOUR
NEXT TREATMENT
Get Allē today for savings on future treatments
Frequently Asked Questions
BOTOX® Cosmetic is the #1 selling treatment of its kind*:
- It’s the first and only treatment FDA approved to temporarily improve the look of moderate to severe frown lines, crow’s feet, and forehead lines.
- Treatment requires minimal downtime. You can return to your daily routine immediately after you leave your specialist’s office
- You may begin to notice results within 24 to 48 hours. Full results in 30 days
- It delivers predictable, subtle results, so you look like you, only with less noticeable facial lines
Join the millions of men and women who make BOTOX® Cosmetic part of what they do to care for their appearance. Ask for the first and only BOTOX® Cosmetic by name.
When you choose BOTOX® Cosmetic, you can trust in its established track record. Backed by over 20 years of published studies, BOTOX® Cosmetic is the most widely researched and studied treatment of its kind, approved for use in 98 countries. The safety and efficacy of BOTOX® Cosmetic have been described in more than 528 peer-reviewed articles in scientific and medical journals.
BOTOX® Cosmetic targets one of the underlying causes of frown lines, crow’s feet and forehead lines — the repeated muscle contractions from frowning, squinting, smiling and raising the eyebrows over the years. Your specialist will inject these muscles with BOTOX® Cosmetic to temporarily reduce muscle activity. You will begin to notice your frown lines between your brows, your crow’s feet lines and your forehead lines temporarily look better.
BOTOX® Cosmetic is also the first and only treatment FDA approved to temporarily improve the appearance of moderate to severe vertical bands connecting the neck and jaw. A variety of factors including platysma muscle contraction can lead to the appearance of bands connecting the jaw and neck. The platysma muscle is a thin superficial muscle that covers the neck and extends over the jawline towards the lower face. Your specialist will inject the platysma muscle with BOTOX® Cosmetic to temporarily reduce muscle activity.
BOTOX® Cosmetic is a biologic product that cannot be substituted and is not equivalent for another product. In fact, the FDA has stated BOTOX® Cosmetic is “not equivalent,” which means that its safety and effectiveness cannot be claimed by any other product. The potency – or strength – of BOTOX® Cosmetic is measured in scientifically defined units that cannot be compared to any other product, due to our unique manufacturing process. There are no substitutes for our product.
People who are prescribed a biologic product have a right to know exactly what they are receiving. Be sure to ask which product you are being prescribed and why.
BOTOX® Cosmetic is a technique-sensitive treatment. You can trust BOTOX® Cosmetic to deliver natural-looking results**† when you are treated by someone who is licensed, trained, and a medical expert in facial anatomy. So you’ll look like yourself—only with less noticeable lines. No one should be able to tell you’ve had anything done.
Compare the before and after pictures of real patients in our gallery, and see the difference for yourself.
Full Results in 30 days. †Forehead lines, frown lines and crow’s feet only.
BOTOX® Cosmetic continues to recognize the importance of true innovation in the aesthetics market and neurotoxin category to address perspectives and needs of patients and providers. This includes:
- Leveraging technology to open education and access for patients interested in aesthetics and neurotoxin treatment.
- Representing diverse patient perspectives and real people through marketing efforts as seen with the See Yourself campaign.
- Investing in a rigorous R and D program to continue clinical development and product innovation. BOTOX® Cosmetic is the only neurotoxin that is FDA approved for four treatment areas: moderate to severe frown lines, crow’s feet, forehead lines, and most recently, vertical bands connecting the neck and jaw.
Be wary of discount products or “cheap” BOTOX® Cosmetic – if it sounds too good to be true, it probably is. Your cost of BOTOX® Cosmetic not only includes the price of the product, but more importantly, the skill and expertise of the specialist or healthcare professional who is administering your treatment.
The best way to save money on your treatments is to enroll in Allē, the aesthetics loyalty program by the makers of BOTOX® Cosmetic. With Allē, you can earn points and rewards for savings on future treatments. It’s easy and free to join!
Become on Allē Member today to avoid missing out on exclusive offers and rewards, from
BOTOX® Cosmetic–and more of your favorite brands.
Not at all! Many men make BOTOX® Cosmetic part of what they do to care for their appearance.
The number of men choosing treatments like BOTOX® Cosmetic has risen fast – in the past three years alone, men have received over one million botulinum toxin treatments. When surveyed, the majority of men say they want to look good and they’re bothered by the changes they see in the mirror. 80% would choose to treat their crow’s feet first, while 74% would prioritize their forehead lines, and 60% would most like to treat their frown lines.†
†Results from a survey of men to determine most likely treatment areas and top areas of concern for injectable-naive,
aesthetically-oriented men aged 30 to 65 years (N=600). Proportion of respondents selecting that area as highest priority to treat using the Maximum Difference (MaxDiff) scaling system.
It’s not your age that determines when BOTOX® Cosmetic is right for you, it’s the severity of your lines. In fact, 64% of plastic surgeons report seeing a rise in cosmetic surgery or injectable treatments for patients in their early 30’s.
The truth is, everyone’s lines form differently. The timing can be influenced by a combination of factors, from cellular changes that may occur over time, to reduction of collagen, to genetic factors, or damage caused by free radicals from the sun and the environment.
Whenever your lines start to bother you, go speak with your doctor. They can help you determine if treatment is right for you.
Your specialist will discuss your treatment goals and perform a facial analysis to determine the appropriate treatment areas for you. If the HCP deems you to be an appropriate candidate, the injection may take place on that same day. Some patients report that being injected with BOTOX® Cosmetic feels like a pinch. Your specialist may use ice to numb the treatment area. Or, if you are concerned about discomfort, your specialist may apply a topical numbing cream before administering your treatment.
Treatment requires minimal downtime. So you can return to your daily routine immediately after you leave your specialist’s office.
You may begin to notice results within 24 to 48 hours, with full results in 30 days, with results lasting up to four months for moderate to severe frown lines. Remember that results vary from patient to patient though, so your physician will plan your next appointment based on your results and aesthetic goals.
Start talking about your goals with a specialist today and find out what you could expect.
Treatment requires minimal downtime. So you can return to your daily routine immediately after you leave your specialist’s office.
Treatment with BOTOX® Cosmetic is customized to your goals and needs. When you meet with your specialist, he or she will determine the appropriate treatment for any areas you wish to address, including moderate to severe frown lines, crow’s feet, forehead lines, and neck bands. Remember, only BOTOX® Cosmetic is approved to treat all four of these areas.
For the crow’s feet area, your specialist will inject 3 areas of the muscle that frames the side of the eye. This will be repeated on the muscle that frames the other eye.
For the frown lines area, your specialist will administer 5 injections into the muscles between your brows and in your forehead.
For the forehead lines area, your specialist will administer 5 injections into a muscle in your forehead.
For vertical bands connecting the neck and jaw, your specialist will administer 8 injections in the jawline and 5 in each band that is presented.
Three percent of patients experienced eyelid drooping in the frown lines studies, one percent of patients experienced eyelid swelling in the crow’s feet studies, and two percent of patients experienced brow drooping in the forehead lines studies. In one platysma prominence study, less than one percent of patients experienced difficulty swallowing or facial paralysis. Other possible side effects include: dry mouth; discomfort, pain, or bleeding at the injection site; tiredness; headache; neck pain; eye problems: double vision, blurred vision, decreased eyesight and dry eyes; and allergic reactions. These are not all of the possible serious side effects of BOTOX® Cosmetic. Please see the Important Safety Information including Boxed Warning and Medication Guide and talk to your specialist.
There is no such thing as a “generic” form of BOTOX® Cosmetic. Be wary of discount products or “cheap” BOTOX® Cosmetic. Medical formulations, potency, and approved doses vary among products, so no one product can take the place of another. FDA labeling states that BOTOX® Cosmetic is not equivalent with any other product. If it doesn’t say BOTOX® Cosmetic on the vial, then it isn’t BOTOX® Cosmetic.
BOTOX® Cosmetic has a one-of-a-kind formulation. And BOTOX® Cosmetic is the most widely researched and studied treatment of its kind. Backed by more than 16 years of published studies, the safety and efficacy of BOTOX® Cosmetic have been described in 528 peer-reviewed articles in scientific and medical journals.
Finally, Allergan, the maker of BOTOX® Cosmetic, owns the entire manufacturing and packaging process, which helps ensure the reliability and safety of each vial.
For proven results, ask for BOTOX® Cosmetic.
SCHEDULE YOUR CONSULTATION TODAY
INDICATIONS, IMPORTANT SAFETY INFORMATION, AND PRESCRIBING INFORMATION
BOTOX® Cosmetic (onabotulinumtoxinA) Important Information
Indications
BOTOX® Cosmetic (onabotulinumtoxinA) is indicated in adult patients for the temporary improvement in the appearance of:
– Moderate to severe glabellar lines associated with corrugator and/or procerus muscle activity
– Moderate to severe lateral canthal lines associated with orbicularis oculi activity
– Moderate to severe forehead lines associated with frontalis activity
– Moderate to severe platysma bands associated with platysma muscle activity
IMPORTANT SAFETY INFORMATION, INCLUDING BOXED WARNING
WARNING: DISTANT SPREAD OF TOXIN EFFECT
Postmarketing reports indicate that the effects of BOTOX® Cosmetic and all botulinum toxin products may spread from the area of injection to produce symptoms consistent with botulinum toxin effects. These may include asthenia, generalized muscle weakness, diplopia, ptosis, dysphagia, dysphonia, dysarthria, urinary incontinence, and breathing difficulties. These symptoms have been reported hours to weeks after injection. Swallowing and breathing difficulties can be life threatening and there have been reports of death. The risk of symptoms is probably greatest in children treated for spasticity, but symptoms can also occur in adults treated for spasticity and other conditions, particularly in those patients who have an underlying condition that would predispose them to these symptoms. In unapproved uses and approved indications, cases of spread of effect have been reported at doses comparable to those used to treat cervical dystonia and spasticity and at lower doses.
CONTRAINDICATIONS
BOTOX® Cosmetic is contraindicated in the presence of infection at the proposed injection site(s) and in individuals with known hypersensitivity to any botulinum toxin preparation or to any of the components in the formulation.
WARNINGS AND PRECAUTIONS
Lack of Interchangeability Between Botulinum Toxin Products
The potency units of BOTOX® Cosmetic are specific to the preparation and assay method utilized. They are not interchangeable with other preparations of botulinum toxin products and, therefore, units of biological activity of BOTOX® Cosmetic cannot be compared to nor converted into units of any other botulinum toxin products assessed with any other specific assay method.
Spread of Toxin Effect
Please refer to Boxed Warning for Distant Spread of Toxin Effect.
No definitive serious adverse event reports of distant spread of toxin effect associated with dermatologic use of BOTOX® Cosmetic at the labeled dose of 20 Units (for glabellar lines), 24 Units (for lateral canthal lines), 40 Units (for forehead lines with glabellar lines), 44 Units (for simultaneous treatment of lateral canthal lines and glabellar lines), and 64 Units (for simultaneous treatment of lateral canthal lines, glabellar lines, and forehead lines) have been reported. Patients or caregivers should be advised to seek immediate medical care if swallowing, speech, or respiratory disorders occur.
Serious Adverse Reactions With Unapproved Use
Serious adverse reactions, including excessive weakness, dysphagia, and aspiration pneumonia, with some adverse reactions associated with fatal outcomes, have been reported in patients who received BOTOX® injections for unapproved uses. In these cases, the adverse reactions were not necessarily related to distant spread of toxin, but may have resulted from the administration of BOTOX® to the site of injection and/or adjacent structures. In several of the cases, patients had pre-existing dysphagia or other significant disabilities. There is insufficient information to identify factors associated with an increased risk for adverse reactions associated with the unapproved uses of BOTOX®. The safety and effectiveness of BOTOX® for unapproved uses have not been established.
Hypersensitivity Reactions
Serious and/or immediate hypersensitivity reactions have been reported. These reactions include anaphylaxis, serum sickness, urticaria, soft-tissue edema, and dyspnea. If such reactions occur, further injection of BOTOX® Cosmetic should be discontinued and appropriate medical therapy immediately instituted. One fatal case of anaphylaxis has been reported in which lidocaine was used as the diluent and, consequently, the causal agent cannot be reliably determined.
Cardiovascular System
There have been reports following administration of BOTOX® of adverse events involving the cardiovascular system, including arrhythmia and myocardial infarction, some with fatal outcomes. Some of these patients had risk factors including pre-existing cardiovascular disease. Use caution when administering to patients with pre-existing cardiovascular disease.
Increased Risk of Clinically Significant Effects With Pre-existing Neuromuscular Disorders
Individuals with peripheral motor neuropathic diseases, amyotrophic lateral sclerosis, or neuromuscular junction disorders (eg, myasthenia gravis or Lambert-Eaton syndrome) should be monitored when given botulinum toxin. Patients with neuromuscular disorders may be at increased risk of clinically significant effects including generalized muscle weakness, diplopia, ptosis, dysphonia, dysarthria, severe dysphagia, and respiratory compromise from onabotulinumtoxinA (see Warnings and Precautions).
Dysphagia and Breathing Difficulties
Treatment with BOTOX® and other botulinum toxin products can result in swallowing or breathing difficulties. Patients with pre-existing swallowing or breathing difficulties may be more susceptible to these complications. In most cases, this is a consequence of weakening of muscles in the area of injection that are involved in breathing or oropharyngeal muscles that control swallowing or breathing (see Boxed Warning).
Pre-existing Conditions at the Injection Site
Caution should be used when BOTOX® Cosmetic treatment is used in the presence of inflammation at the proposed injection site(s) or when excessive weakness or atrophy is present in the target muscle(s).
Dry Eye in Patients Treated With BOTOX® Cosmetic
There have been reports of dry eye associated with BOTOX® Cosmetic injection in or near the orbicularis oculi muscle. If symptoms of dry eye (eg, eye irritation, photophobia, or visual changes) persist, consider referring patients to an ophthalmologist.
Human Albumin and Transmission of Viral Diseases
This product contains albumin, a derivative of human blood. Based on effective donor screening and product manufacturing processes, it carries an extremely remote risk for transmission of viral diseases and variant Creutzfeldt-Jakob disease (vCJD). There is a theoretical risk for transmission of Creutzfeldt-Jakob disease (CJD), but if that risk actually exists, the risk of transmission would also be considered extremely remote. No cases of transmission of viral diseases, CJD or vCJD have ever been identified for licensed albumin or albumin contained in other licensed products.
ADVERSE REACTIONS
The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for glabellar lines were eyelid ptosis (3%), facial pain (1%), facial paresis (1%), and muscular weakness (1%).
The most frequently reported adverse reaction following injection of BOTOX® Cosmetic for lateral canthal lines was eyelid edema (1%).
The most frequently reported adverse reactions following injection of BOTOX® Cosmetic for forehead lines with glabellar lines were headache (9%), brow ptosis (2%), and eyelid ptosis (2%).
The safety profile of BOTOX® Cosmetic treatment of platysma bands is consistent with the known safety profile of BOTOX® Cosmetic for other indications.
DRUG INTERACTIONS
Co-administration of BOTOX® Cosmetic and aminoglycosides or other agents interfering with neuromuscular transmission (eg, curare-like compounds) should only be performed with caution as the effect of the toxin may be potentiated. Use of anticholinergic drugs after administration of BOTOX® Cosmetic may potentiate systemic anticholinergic effects.
The effect of administering different botulinum neurotoxin products at the same time or within several months of each other is unknown. Excessive neuromuscular weakness may be exacerbated by administration of another botulinum toxin prior to the resolution of the effects of a previously administered botulinum toxin.
Excessive weakness may also be exaggerated by administration of a muscle relaxant before or after administration of BOTOX® Cosmetic.
USE IN SPECIFIC POPULATIONS
There are no studies or adequate data from postmarketing surveillance on the developmental risk associated with use of BOTOX® Cosmetic in pregnant women. There are no data on the presence of BOTOX® Cosmetic in human or animal milk, the effects on the breastfed child, or the effects on milk production.
Please see BOTOX® Cosmetic full Prescribing Information including Boxed Warning and Medication Guide.
